PDS Biotechnology Corporation
PDSBNASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $59.28M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.20$1.79
- Volume (live)
- -
- Avg. volume (3M)
- 30.75M
PDS Biotechnology (PDSB) Stock Price & Financial Analysis
PDS Biotechnology Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.03 - $1.10 |
|---|---|
| 52-Week High | $1.79 |
| 52-Week Low | $0.20 |
| Open | $1.07 |
| Volume (last close) | 2.29M |
| Average Volume (3M) | 30.75M |
| 50-Day MA | $0.63 |
|---|---|
| 200-Day MA | $0.82 |
| 1-Year Change | +26.11% |
| Market Cap | 59.28M |
|---|---|
| Shares Outstanding | 55.66M |
| Price to Book (P/B) | -16.56 |
| EV/EBITDA | -2.33 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
PDS Biotechnology at a Glance
As of the Oct 26, 2026 close, PDS Biotechnology (PDSB) has a market capitalization of $59.28M.
As of its latest reported balance sheet, it holds $5.60M in cash and securities against $4.33M of debt, a net cash position of $1.26M.
PDS Biotechnology does not currently pay a dividend.
The share price is up 26.1% over the past year. At $1.06 (the Oct 26, 2026 close) it sits within its 52-week range of $0.20 to $1.79, above its 200-day moving average of $0.82.
Frequently Asked Questions About PDS Biotechnology
What is the current stock price for PDSB?
As of the Oct 26, 2026 close, PDSB stock trades at $1.06. The 52-week range is $0.20–$1.79, with a day range of $1.03–$1.10.
What is the P/E ratio for PDSB?
The P/E ratio (Price-to-Earnings) for PDSB is shown in the Key Statistics section. This valuation metric helps compare PDS Biotechnology Corporation to industry peers.
Does PDSB pay dividends?
PDS Biotechnology does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for PDSB?
Analyst ratings and recommendations for PDSB are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of PDSB?
As of the Oct 26, 2026 close, PDS Biotechnology's market capitalization is $59.3M, classifying it as a micro-cap company. PDS Biotechnology operates in the Healthcare sector within the Biotechnology industry.